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2010-2011 Influenza Season 
Week 17 ending April 30, 2011 
All data are preliminary and may change as more reports are received. 
 
Synopsis: During week 17 (April 24-30, 2011), influenza activity in the United States continued to 
decrease.  
o Of the 1,901 specimens tested by U.S. World Health Organization (WHO) and National 
Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and 
reported to CDC/Influenza Division, 69 (3.6%) were positive for influenza. 
o The proportion of deaths attributed to pneumonia and influenza (P&I) was below the 
epidemic threshold. 
o Three influenza-associated pediatric deaths were reported, bringing the season total to 100. 
One of these deaths was associated with a 2009 influenza A (H1N1) virus, one was 
associated with an influenza A virus for which the subtype was not determined, and one was 
associated with an influenza B virus. 
o The proportion of outpatient visits for influenza-like illness (ILI) was 1.3%, which is below the 
national baseline of 2.5%. All 10 regions reported ILI below region-specific baselines. All 50 
states and New York City experienced minimal ILI activity, and the District of Columbia had 
insufficient data to calculate an ILI activity level. 
o The geographic spread of influenza in two states was reported as regional; the District of 
Columbia and seven states reported local influenza activity; Puerto Rico and 33 states 
reported sporadic influenza activity, and the U.S. Virgin Islands, Guam, and eight states 
reported no influenza activity. 
 
National and Regional Summary of Select Surveillance Components 
 Data for current week Data cumulative since October 3, 2010 (Week 40) 
HHS 
Surveillance 
Regions* 
Out-
patient 
ILI† 
% 
positive 
for flu‡ 
Number of 
jurisdictions 
reporting 
regional or 
widespread 
activity§ 
A (H3) 
2009 A 
(H1N1) 
A 
(Subtyping not 
performed) 
B 
Pediatric 
Deaths 
Nation Normal 3.6% 2 of 54 16,795 10,902 11,340 13,682 100 
Region 1 Normal 13.5% 1 of 6 1,717 913 97 456 3 
Region 2 Normal 8.5% 1 of 4 760 369 1,117 463 11 
Region 3 Normal 5.3% 0 of 6 2,973 2,568 858 1,029 10 
Region 4 Normal 3.3% 0 of 8 1,479 1,431 3,161 3,955 17 
Region 5 Normal 20.2% 0 of 6 2,120 1,532 446 1,323 20 
Region 6 Normal 1.5% 0 of 5 2,191 562 2,306 2,567 17 
Region 7 Normal 2.5% 0 of 4 712 539 288 678 1 
Region 8 Normal 3.5% 0 of 6 1,732 689 2,122 1,884 7 
Region 9 Normal 2.8% 0 of 5 1,994 1,472 756 1,192 12 
Region 10 Normal 7.3% 0 of 4 1,117 827 189 135 2 
*HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, U.S. Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, 
SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; 
and Region 10: AK, ID, OR, WA). 
† Elevated means the % of visits for ILI is at or above the national or region-specific baseline. 
‡ National data are for current week; regional data are for the most recent three weeks. 
§ Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. 
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U.S. Virologic Surveillance: WHO and NREVSS collaborating laboratories located in all 50 states 
and Washington, D.C., report to CDC the number of respiratory specimens tested for influenza and 
the number positive by influenza type and subtype. The results of tests performed during the 
current week are summarized in the table below. 
 
 Week 17 
No. of specimens tested 1,901 
No. of positive specimens (%) 69 (3.6%) 
Positive specimens by type/subtype  
Influenza A 36 (52.2%) 
          A (2009 H1N1)   6 (16.7%)             
          A (subtyping not performed)          11 (30.6%) 
          A (H3)                19 (52.8%)     
Influenza B 33 (47.8%) 
 
All influenza types and subtypes were identified at high levels this season, but in recent weeks have 
circulated at much lower levels. The predominant virus has varied by week, region, and even 
between states within the same region. In recent weeks the proportion of influenza B viruses 
identified nationally and in some regions has been increasing and in week 17 five of the 10 regions 
(Regions 1, 3, 5, 7, and 8) identified at least half of all influenza-positive specimens as influenza B 
viruses. 
 
Influenza Positive Tests Reported to CDC by U.S. WHO/NREVSS 
Collaborating Laboratories, National Summary, 2010-11 Season 
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Aggregate Hospitalization and Death Reporting Activity (AHDRA): This system tracks weekly 
counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was 
implemented on August 30, 2009, during the 2009 H1N1 pandemic, and ended on April 4, 2010. 
AHDRA surveillance during the 2010-11 season has continued on a voluntary basis, and 19 
jurisdictions reported during week 17. From October 3, 2010 – April 30, 2011, 16,328 laboratory-
confirmed influenza-associated hospitalizations and 310 laboratory-confirmed influenza-associated 
deaths were reported to CDC. 
  
Weekly Laboratory-Confirmed Influenza-Associated Hospitalizations and 
Deaths, National Summary, 2010-11 Season 
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Antigenic Characterization: CDC has antigenically characterized 2,182 influenza viruses [518 
2009 influenza A (H1N1) viruses, 997 influenza A (H3N2) viruses, and 667 influenza B viruses] 
collected by U.S. laboratories since October 1, 2010. 
2009 Influenza A (H1N1) [518] 
 Five hundred seventeen (99.8%) of the 518 tested were characterized as 
A/California/7/2009-like, the influenza A (H1N1) component of the 2010-11 influenza 
vaccine for the Northern Hemisphere. One virus (0.2%) of the 518 tested showed 
reduced titers with antiserum produced against A/California/7/2009. 
 
Influenza A (H3N2) [997] 
 Nine hundred sixty-two (96.5%) of the 997 tested were characterized as 
A/Perth/16/2009-like, the influenza A (H3N2) component of the 2010-11 influenza 
vaccine for the Northern Hemisphere. Thirty-five (3.5%) of the 997 tested showed 
reduced titers with antiserum produced against A/Perth/16/2009. 
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Influenza B (B/Victoria/02/87 and B/Yamagata/16/88 lineages) [667] 
Victoria Lineage [629] 
 Six hundred twenty-nine (94.3%) of the 667 influenza B viruses tested belong to the 
B/Victoria lineage of viruses. 
o Six hundred twenty-eight (99.8%) of these 629 viruses were characterized as 
B/Brisbane/60/2008-like, the recommended influenza B component for the 
2010-11 Northern Hemisphere influenza vaccine. 
o One (0.2%) of these 629 viruses showed somewhat reduced titers with 
antisera produced against B/Brisbane/60/2008. 
Yamagata Lineage [38] 
 Thirty-eight (5.7%) of the 667 viruses were identified as belonging to the B/Yamagata 
lineage of viruses. 
Antiviral Resistance: Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B 
virus isolates for resistance to the neuraminidase inhibitors (oseltamivir and zanamivir) is performed 
at CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for 
a single known mutation in the neuraminidase protein of the virus that confers oseltamivir 
resistance (H275Y). The data summarized in the table below combine the results of both test 
methods and include samples that were tested as part of routine surveillance purposes; it does not 
include diagnostic testing specifically done because of clinical suspicion of antiviral resistance. 
High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 
influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B 
viruses) circulating globally. As a result of the sustained high levels of resistance, data from 
adamantane resistance testing are not presented weekly in the table below.    
Neuraminidase Inhibitor Resistance Testing Results 
on Samples Collected Since October 1, 2010. 
 
Virus 
Samples 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Virus 
Samples 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Oseltamivir Zanamivir 
Seasonal 
Influenza A 
(H1N1) 
0 0 (0.0) 0 0 (0.0) 
Influenza A 
(H3N2) 
684 2 (0.3) 662 0 (0.0) 
Influenza B 641 0 (0.0) 641 0 (0.0) 
2009 
Influenza A 
(H1N1) 
3,188* 32 (1.0) 441 0 (0.0) 
*Includes specimens tested in national surveillance and additional specimens tested at public health 
laboratories in six states (CA, ME, MD, MN, TX, and WA) who share testing results with CDC. 
 
To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of 
the need to continue hand and cough hygiene measures for the duration of any symptoms of 
influenza, even while taking antiviral medications. Additional information on antiviral 
recommendations for treatment and chemoprophylaxis of influenza virus infection is available at 
http://www.cdc.gov/flu/antivirals/index.htm.   
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Pneumonia and Influenza (P&I) Mortality Surveillance: During week 17, 7.2% of all deaths 
reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was 
below the epidemic threshold of 7.6% for week 17. 
 
Pneumonia and Influenza Mortality for 122 U.S. Cities 
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Influenza-Associated Pediatric Mortality: Three influenza-associated pediatric deaths were 
reported to CDC during week 17. One of these deaths was associated with a 2009 influenza A 
(H1N1) virus, one was associated with an influenza A virus for which the subtype was not 
determined, and one was associated with an influenza B virus. 
 
One-hundred influenza-associated pediatric deaths from 33 states, Chicago, and New York City 
have been reported during this influenza season. Forty of the 100 deaths reported were associated 
with influenza B viruses; 25 were associated with 2009 influenza A (H1N1) viruses; 17 deaths 
reported were associated with influenza A (H3N2) viruses, and 18 were associated with an 
influenza A virus for which the subtype was not determined.   
 
Number of Influenza-Associated Pediatric Deaths by Week of Death: 
2007-08 season to present 
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2009-10
Number of Deaths 
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Deaths Reported Current WeekDeaths Reported Previous Week
2010-11
Number of Deaths 
Reported =  100
 
 
Influenza-Associated Hospitalizations: FluSurv-NET conducts population-based surveillance for 
laboratory-confirmed influenza-associated hospitalizations in children (persons younger than 18 
years) and adults. The current network covers more than 80 counties in the 10 Emerging Infections 
Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states 
(ID, MI, OH, OK, RI, and UT). 
 
The current season’s rates include cases from October 1, 2010 to April 30, 2011. 
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Please note the following: (i) The scale of the vertical axis on the Cumulative Hospitalization Rate figures will be adjusted 
during the season to make the graphs easier to read; (ii) FluSurv-NET was created during the 2009-2010 season when 
surveillance in six states was added to ongoing surveillance for influenza-associated hospitalizations in10 EIP states. 
During the 2009-2010 season, FluSurv-NET included sites in the 10 EIP sites and sites in IA, ID, MI, ND, OK, and SD; (iii) 
the 2008-2009 EIP season ended April 14, 2009, due to the onset of the 2009 H1N1 pandemic. 
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1
Asthma may include a diagnosis of asthma and reactive airway disease; Cardiovascular diseases may include conditions 
such as coronary heart disease, cardiac valve disorders, congestive heart failure, pulmonary hypertension, and aortic 
stenosis; Chronic lung diseases may include conditions such as bronchiolitis obliterans, chronic aspiration pneumonia, 
and interstitial lung disease; Immune suppression may include conditions such as immunoglobulin deficiency, leukemia, 
lymphoma, HIV/AIDS, and individuals taking immunosuppressive medications; Metabolic disorders may include conditions 
such as diabetes mellitus, thyroid dysfunction, adrenal insufficiency, and liver disease; Neurologic diseases may include 
conditions such as seizure disorders, neuromuscular disorders, and cognitive dysfunction; Obesity was defined as a body 
mass index (BMI) greater than 30 kg/m
2
 in patients 20 years of age or older, or equal to or greater than the 95
th
 percentile 
of a patient’s age and sex category in patients under 20 years of age; Renal diseases may include conditions such as 
acute or chronic renal failure, nephrotic syndrome, glomerulonephritis, and impaired creatinine clearance. 
2
Data as of May 3, 2011.  Includes 3,894 (of a total 5,957 reported) cases for which data collection has been completed 
through the medical chart review stage. 
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Demographic and clinical characteristics of laboratory-confirmed, influenza-
associated hospitalizations identified in EIP1 and FluSurv-NET2 sites, 2006-2011 
  2010-2011 
FluSurv-NET
3
 
N (%) 
2009-2010 
FluSurv-NET 
N (%) 
2008-2009 
EIP 
N (%) 
2007-2008 
EIP 
N (%) 
2006-2007 
EIP 
N (%) 
Total Cases 5,957 7,517 1,698 3,930 1,279 
Age in Years           
0-4 892 (15.0) 1,326 (17.6) 549 (32.3) 639 (16.3) 393 (30.7) 
5-17 423 (7.1) 1,204 (16.0) 244 (14.4) 221 (5.6) 130 (10.2) 
18-49 1,467 (24.6) 2,779 (37.0) 374 (22.0) 736 (18.7) 246 (19.2) 
50-64 1,146 (19.2) 1,458 (19.4) 201 (11.8) 585 (14.9) 155 (12.1) 
65+ 2,026 (34.0) 750 (10.0) 330 (19.4) 1,749 (44.5) 355 (27.8) 
Sex           
Male 2,763 (46.4) 3,517 (46.8) 832 (49.0) 1,825 (46.4) 631 (49.3) 
Female 3,189 (53.5) 4,000 (53.2) 866 (51.0) 2,104 (53.5) 648 (50.7) 
Flu Type and Subtype           
Influenza A 4,886 (82.0) 7,355 (97.8) 1,236 (72.8) 2,562 (65.2) 1,082 (84.6) 
       Specimens subtyped
4
 1,747 5,325 -- -- -- 
            A (H1) 0 (0.0) 0 (0.0) -- -- -- 
            A (H3) 1,163 (66.6) 3 (0.1) -- -- -- 
            A (2009 H1N1) 584 (33.4) 5,322 (99.9) -- -- -- 
Influenza B 967 (16.2) 52 (0.7) 382 (22.5) 1,199 (30.5) 149 (11.6) 
Intensive Care Unit 657 (16.9) 1,560 (20.8) 298 (17.6) 495 (12.6) 198 (15.5) 
Mechanical Ventilation 302 (7.8) 758 (10.1) 157 (9.2) 252 (6.4) 111 (8.7) 
Diagnosis of Pneumonia 1,125 (28.9) 2,804 (37.3) 407 (24.0) 1,220 (31.0) 404 (31.6) 
Died 101 (2.6) 222 (3.0) 49 (2.9) 104 (2.6) 24 (1.9) 
 
Columns may not sum to 100% due to missing or unknown values. 
1
Surveillance in EIP states (CA, CO, CT, GA, MD, MN, NM, NY, OR, TN) was conducted from 2006-2011. 
2
FluSurv-Net includes surveillance at EIP sites and at sites in additional states (IA, ID, MI, ND, OK, SD in 2009-2010; ID, 
MI, OH, OK, RI, UT in 2010-2011). 
3
Data as of May 3, 2011.  Results describing influenza A subtype, intensive care unit admission, mechanical ventilation, 
diagnosis of pneumonia, and death are from 3,894 (of a total 5,957 reported) cases for which data collection has been 
completed through the medical chart review stage. 
4
Influenza A subtype results are available beginning with the 2007-2008 season. Percentages for influenza A subtypes 
are calculated using the number of influenza A specimens that were subtyped as a denominator. 
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Outpatient Illness Surveillance: Nationwide during week 17, 1.3% of patient visits reported 
through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to 
influenza-like illness (ILI). This percentage is below the national baseline of 2.5%.  
 
Percentage of Visits for Influenza-like Illness (ILI) Reported by  
the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), 
Weekly National Summary, September 30, 2007 – April 30, 2011 
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On a regional level, the percentage of outpatient visits for ILI ranged from 0.6% to 2.4% during 
week 17. All 10 regions reported ILI below region-specific baselines. 
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Region 6 - AR, LA, NM, OK, TX
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Region 2 - NJ, NY, USVI
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Region 4 - AL, FL, GA, KY, MS, NC, SC, TN
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Region 8 - CO, MT, ND, SD, UT, WY
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Region 9 - AZ, CA, HI, NV
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Region 10 - AK, ID, OR, WA
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NOTE: Scales differ between regions
*Use of the regional baselines for state data is not appropriate. 
Baseline*% ILI
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ILINet State Activity Indicator Map: Data collected in ILINet are used to produce a measure of ILI 
activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI 
and are compared to the average percent of ILI visits that occur during spring and fall weeks with 
little or no influenza virus circulation. Activity levels range from minimal, which would correspond to 
ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI 
activity from outpatient clinics being much higher than the average. Because the clinical definition of 
ILI is very general, not all ILI can be attributed to influenza; however, when combined with 
laboratory data, the information on ILI activity can provide a better picture of influenza activity in the 
United States. 
 
During week 17, the following ILI activity levels were experienced: 
 Minimal ILI activity was experienced by all 50 states and New York City.  
 The District of Columbia had insufficient data to calculate an activity level. 
 
Interactive web tool available at: http://gis.cdc.gov/grasp/fluview/main.html 
*This map uses the proportion of outpatient visits to health care providers for influenza-like illness to measure the ILI activity level within a state. It does not, 
however, measure the extent of geographic spread of flu within a state. Therefore, outbreaks occurring in a single city could cause the state to display high 
activity levels. 
Data collected in ILINet may disproportionately represent certain populations within a state, and therefore, may not accurately depict the full picture of 
influenza activity for the whole state. 
Data displayed in this map are based on data collected in ILINet, whereas the State and Territorial flu activity map are based on reports from state and 
territorial epidemiologists. The data presented in this map is preliminary and may change as more data is received. 
Differences in the data presented by CDC and state health departments likely represent differing levels of data completeness with data presented by the 
state likely being the more complete.  
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Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists: The 
influenza activity reported by state and territorial epidemiologists indicates geographic spread of 
influenza viruses, but does not measure the severity of influenza activity. 
 
During week 17, the following influenza activity was reported: 
 No states reported widespread influenza activity. 
 Regional influenza activity was reported by two states (New Hampshire and New York). 
 Local influenza activity was reported by the District of Columbia and seven states 
(Connecticut, Georgia, Maine, Massachusetts, New Jersey, Oregon, and Vermont). 
 Sporadic influenza activity was reported by Puerto Rico and 33 states (Alabama, Alaska, 
Arizona, California, Colorado, Florida, Hawaii, Illinois, Iowa, Kansas, Louisiana, Maryland, 
Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Mexico, 
North Dakota, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, 
Texas, Virginia, Washington, West Virginia, Wisconsin, and Wyoming). 
 The U.S. Virgin Islands, Guam, and eight states (Arkansas, Delaware, Idaho, Indiana, 
Kentucky, North Carolina, Rhode Island, and Utah) reported no influenza activity. 
 
 
 
 
 
 
 
2010-11 Influenza Season – Week 17, ending April 30, 2011           
 
14 
 
 
Additional National and International Influenza Surveillance Information 
 
Distribute Project: Additional information on the Distribute syndromic surveillance project, 
developed and piloted by the International Society for Disease Surveillance (ISDS), now working in 
collaboration with CDC to enhance and support Emergency Department (ED) surveillance, is 
available at http://isdsdistribute.org/. 
 
Google Flu Trends: Google Flu Trends uses aggregated Google search data in a model created in 
collaboration with CDC to estimate influenza activity in the United States. For more information and 
activity estimates from the U.S. and worldwide, see http://www.google.org/flutrends/. 
 
Europe: For the most recent influenza surveillance information from Europe, please see 
WHO/Europe at http://www.euroflu.org/index.php and visit the European Centre for Disease 
Prevention and Control at 
http://ecdc.europa.eu/en/publications/surveillance_reports/influenza/Pages/weekly_influenza_survei
llance_overview.aspx. 
 
Public Health Agency of Canada: The most up-to-date influenza information from Canada is 
available at http://www.phac-aspc.gc.ca/fluwatch/. 
 
World Health Organization FluNet: Additional influenza surveillance information from participating 
WHO member nations is available at http://gamapserver.who.int/GlobalAtlas/home.asp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A description of surveillance methods is available at: http://www.cdc.gov/flu/weekly/overview.htm 
Report prepared: May 6, 2011. 
